AbbVie Gets Even More Complicated With Allergan Seeking Alpha AbbVie dropped to *fresh* 52-week lows following the $63B takeover bid for Allergan. AbbVie had already been facing substantial challenges prior to that deal ... View full coverage on Google News AbbVie Gets Even More Complicated With Allergan - Seeking Alpha Read More |
0 Response to "AbbVie Gets Even More Complicated With Allergan - Seeking Alpha"
Posting Komentar